EK
EKGGF.US CardioComm Solutions Inc
- Market cap
- USD 1.34M
- P/E
- -
- P/B
- 71.03x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is EKGGF.US undervalued?
Graham numberThe Graham number of CardioComm Solutions Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CardioComm Solutions Inc fundamental analysis
No fundamental analysis for CardioComm Solutions Inc yet.
CardioComm Solutions Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CardioComm Solutions Inc
CardioComm Solutions, Inc. develops and sells advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, GlobalCardio, and HeartCheck SMART monitoring. It also provides healthcare professional mo…
Full company profileCardioComm Solutions Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CardioComm Solutions Inc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.56M | 1.74M | 1.08M | 875K | 835K | 683K | 996K | 876K | 527K | 272K | 361K |
| Gross Profit | 442K | 1.54M | 778K | 693K | 735K | 637K | 740K | 749K | 508K | -230K | 285K |
| Operating Income | 8.13K | 162K | -577K | -411K | 6.05K | -142K | 6.24K | -116K | -261K | -572K | -396K |
| EBITDA | 37.7K | 107K | -507K | -973K | 19.9K | 58.6K | 51.0K | -44.2K | -128K | -543K | -396K |
| Net Income | -23.1K | 39.6K | -577K | -1.06M | -63.6K | 283.00 | -2.46K | -97.3K | -195K | -529K | -549K |
| EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 1.15M | 1.54M | 1.09M | 323K | 361K | 486K | 280K | 342K | 219K | 155K | 196K |
| Total Liabilities | 1.16M | 1.05M | 1.16M | 1.22M | 1.03M | 910K | 687K | 847K | 495K | 844K | 1.16M |
| Shareholders' Equity | -7.74K | 489K | -68.4K | -896K | -670K | -423K | -407K | -505K | -277K | -689K | -964K |
| Cash & Short-term Investments | 211K | 349K | 140K | 81.2K | 122K | 108K | 56.3K | 90.9K | 64.0K | 47.0K | 38.3K |
| Total Debt | 600K | 600K | 600K | 536K | 306K | 437K | 345K | 489K | 282K | 691K | 923K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -150K | -292K | -193K | -61.9K | 39.4K | -121K | 54.5K | -54.1K | -111K | -453K | -427K |
| Capital Expenditure | 2.58K | 3.34K | 16.2K | 8.50K | 16.0K | 2.63K | 10.2K | 2.02K | 5.00K | 2.51K | 1.30K |
| Free Cash Flow | -153K | -295K | -209K | -70.4K | 23.4K | -123K | 44.3K | -56.1K | -116K | -455K | -428K |
| Ratios | |||||||||||
| ROE | - | 8.1% | - | - | - | - | - | - | - | - | - |
| ROA | -2.0% | 2.6% | -53.0% | -328.4% | -17.6% | 0.1% | -0.9% | -28.5% | -89.0% | -341.5% | -279.9% |
| Net Profit Margin | -1.5% | 2.3% | -53.7% | -121.4% | -7.6% | 0.0% | -0.2% | -11.1% | -36.9% | -194.6% | -152.3% |
| Debt to Equity | - | 1.23x | - | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CardioComm Solutions Inc dividends
CardioComm Solutions Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:5 on Nov 26, 2007.
Who owns CardioComm Solutions Inc
- Insiders 47.45%
- Institutions 0.00%
- Public & others 52.55%
- Shares outstanding 198M
- Free float 111M
CardioComm Solutions Inc company profile
- Company name
- CardioComm Solutions Inc
- Ticker
- EKGGF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- 18 Wynford Drive, Toronto, ON, Canada, M3C 3S2
- Phone
- 416 977 9425
- Website
- cardiocommsolutions.com
About CardioComm Solutions Inc
CardioComm Solutions, Inc. develops and sells advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, GlobalCardio, and HeartCheck SMART monitoring. It also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.
CardioComm Solutions Inc management
3- Mr. Robert E. CainesChairman & CFO
- Mr. Etienne Grima CHE, MScCEO, Corporate Secretary & Director
- Dr. Branislav Vasilijevic Ph.D.Director of Software Engineering